Bharat Parenterals approves FY26 financials, dividend at 33rd AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Bharat Parenterals Limited concluded its 33rd AGM on September 19, 2026
  • Shareholders approved audited financial statements for the year ended March 31, 2026
  • A final dividend for FY26 was declared by the members
  • Mr. Hemang Shah was reappointed as Executive Director
  • Statutory and secretarial audit reports were unqualified
powered bylight_fuzz_icon
51352098

*this image is generated using AI for illustrative purposes only.

Bharat Parenterals Limited concluded its 33rd Annual General Meeting on September 19, 2026. The meeting was held via video conferencing from its registered office in Vadodara, Gujarat.

Members approved the audited financial statements for the fiscal year ended March 31, 2026. The company also declared a final dividend for FY26 during the proceedings.

Key Resolutions Passed

The shareholders passed several ordinary resolutions during the meeting. Key decisions included the reappointment of board members and ratification of auditor fees.

Resolution Type Details Status
Financial Approval Adoption of audited financials for FY26 Passed
Dividend Declaration Final dividend for FY26 Passed
Board Reappointment Reappointment of Mr. Hemang Shah as Executive Director Passed
Auditor Fees Ratification of remuneration for M/S. CMA Chetan Gandhi Passed
Related Party Transactions Approval of related party transactions Passed

Mr. Hemang Shah retires by rotation and offered himself for reappointment as Executive Director. Members approved his reappointment. The company also ratified the remuneration payable to M/S. CMA Chetan Gandhi, Cost Accountants, for the financial year ending March 31, 2027.

Meeting Proceedings

Mr. Bharatkumar Desai, Chairman & Managing Director, addressed the members. He provided an overview of the company’s financial performance and future outlook. The statutory auditors’ report dated May 18, 2026, and the secretarial auditors’ report dated August 5, 2026, were unqualified with no adverse observations.

Remote e-voting commenced on September 16, 2026, at 9:00 am and concluded on September 18, 2026, at 5:00 pm. E-voting was also available during the AGM for members present who had not voted remotely. M/S. Jigar Trivedi & Co acted as the scrutinizer for the voting process.

Historical Stock Returns for Bharat Parenterals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.58%-3.14%+15.51%+15.51%+15.51%+15.51%

How will the declared final dividend for FY26 impact the company's payout ratio and future capital allocation strategies?

What specific growth initiatives or capacity expansion plans did Mr. Bharatkumar Desai outline during his address on the company's future outlook?

How might the reappointment of Mr. Hemang Shah as Executive Director influence the company's strategic direction in the parenteral pharmaceuticals market?

Bharat Parenterals files FY26 annual report; AGM on September 19

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Bharat Parenterals filed its FY26 annual report with BSE on August 27, 2026
  • The 33rd AGM is scheduled for September 19, 2026, via video conferencing
  • Record date for dividend eligibility is September 12, 2026
  • Remote e-voting facility is provided by NSDL
powered bylight_fuzz_icon
49106591

*this image is generated using AI for illustrative purposes only.

Bharat Parenterals Limited has filed its annual report for the financial year 2025-26 with the Bombay Stock Exchange. The filing was made on August 27, 2026, pursuant to Regulation 34(1)(a) of the SEBI Listing Regulations.

Annual Report Filing and AGM Notice

The company submitted the document to the Corporate Relations Department at BSE Limited. The annual report includes the notice for the 33rd Annual General Meeting (AGM), which is scheduled to be held on Saturday, September 19, 2026. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means.

The annual report is also available on the company’s website at www.bplindia.in . Sharmin Soni, the Company Secretary and Compliance Officer, signed the communication dated August 27, 2026.

Record Date and Dividend Eligibility

Shareholders whose names appear in the books as Beneficial Owners as at the close of business hours on September 12, 2026, will be entitled to receive the dividend. This date also serves as the cut-off for ascertaining the names of members eligible to cast their votes electronically in respect of the businesses to be transacted at the AGM.

The company has issued this intimation pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investors are urged to ensure their KYC details, including PAN and bank account information, are updated with their Depository Participants to avoid any issues with dividend processing or folio freezing. Members holding shares in physical form are requested to consider dematerializing their holdings to ensure compliance with SEBI guidelines and to facilitate faster and safer transactions.

AGM Details and Logistics

The 33rd AGM will commence at 11:00 am on September 19, 2026. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means, in compliance with applicable regulatory circulars. The venue of the meeting shall be deemed to be the Registered Office of the company at Survey No. 144-A, Jarod-Samlaya Road, Vill. Haripura, Ta. Savli, Dist. Vadodara - 391520 (Guj.) India.

Shareholders can attend the proceedings via an electronic platform. The notice of the AGM, along with the Annual Report for FY25-26, will be dispatched electronically to members who have registered their email addresses with the company or their Depository Participants.

In accordance with Regulation 36(1)(b) of the SEBI Listing Regulations, the company has dispatched a letter to those members whose email addresses are not registered. The letter provides a web-link to access the Annual Report and the AGM Notice. These documents are also available on the company’s website at www.bplindia.in under Home → Investors → Annual Report → 2025-26.

Members holding shares in physical form or those who have not registered their email addresses are advised to update their details to receive the documents and login credentials for e-voting. The company has engaged NSDL as the authorized agency to facilitate remote e-voting and voting during the meeting.

E-Voting Process

Pursuant to Section 108 of the Companies Act, 2013, and SEBI Listing Regulations, members will have the opportunity to cast their votes using remote e-voting or the e-voting system available during the AGM. Detailed instructions for joining the meeting and casting votes will be provided in the official notice of the AGM.

For queries, members may contact the Registrar and Transfer Agent, Adroit Corporate Services Private Limited, at info@adroitcorporate.com . Forms for nomination and KYC updation are available on the company website.

Historical Stock Returns for Bharat Parenterals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.58%-3.14%+15.51%+15.51%+15.51%+15.51%

What dividend per share amount is proposed for FY25-26, and how does it compare to the previous year's payout?

How did Bharat Parenterals perform financially in FY25-26, particularly regarding revenue growth and net profit margins?

Are there any strategic acquisitions, new product launches, or capacity expansion plans outlined in the annual report for the upcoming fiscal year?

More News on Bharat Parenterals

1 Year Returns:+15.51%